Dr. Ahmad K. Nooristani, MD

Dr. Nooristani practices at Convalescent Care Center in San Luis Obispo, California.

Dr. Nooristani's NPI, 1659537306, was assigned on August 1, 2008. Dr. Nooristani holds California license A104544.

Dr. Nooristani's primary practice is Convalescent Care Center, at 525 Bluerock Dr, San Luis Obispo, CA 93401 in San Luis Obispo County. The practice phone is (805) 737-3367.

Dr. Nooristani's primary practice is Convalescent Care Center in San Luis Obispo, California. Dr. Nooristani is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is ApolloMD. Dmand AI also links Dr. Nooristani to 3 more hospitals, 5 skilled nursing facilities, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nooristani practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Nooristani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Nooristani is licensed in California.

CMS data shows 9,756 Medicare services from Dr. Nooristani across 12 procedure codes in 2024, for 1,143 Medicare patients. Medicare paid $652,632 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,143 Medicare patients who saw Dr. Nooristani in 2024. The largest group is 65 to 74, with 354 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nooristani's median patient age at 76, with 52% women.

In 2024, Dr. Nooristani wrote 12,779 Medicare Part D claims for 480 patients. 85% of them were for generic drugs. CMS names the drug for 12,046 of them, across 158 drugs with 11 or more claims each, at $483,326 in total drug cost. In 2023, CMS named 8,514 claims across 144 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 19 out of 100 for Dr. Nooristani for performance year 2024, reported individually. Dr. Nooristani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Nooristani from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Ceribell, Inc. paid the most, $25.